Louis Boon

Louis is the CSO and Management Board Member of JJP Biologics, an innovative new Polish Company backed by the Starak family. JJP Biologics develops the next generation of novel therapeutic biologics for I&I and oncology (JJP Biologics: Overview | LinkedIn). Louis was the founder of various companies focused on the generation and development of therapeutic monoclonal antibodies, primarily in the field of cancer and inflammation. Louis is an author of over 400 publications in international scientific journals in the field of medical biotechnology and an inventor at more than 20 patent applications.